Molecular Partners Financials

Molecular Partners Stock Summary

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland. MOLECULAR PARTNERS operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 163 people.

Molecular Partners Key Financial Ratios

There are many critical financial ratios that Molecular Partners' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Molecular Partners reports annually and quarterly.

Molecular Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Molecular Partners's current stock value. Our valuation model uses many indicators to compare Molecular Partners value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Molecular Partners competition to find correlations between indicators driving Molecular Partners's intrinsic value. More Info.Molecular Partners AG is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.51  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Molecular Partners AG is roughly  1.97 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Molecular Partners' earnings, one of the primary drivers of an investment's value.

Molecular Partners Market Pulse

Along with financial statement analysis, the daily predictive indicators of Molecular Partners help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Molecular Partners AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Molecular Partners AG based on widely used predictive technical indicators. In general, we focus on analyzing Molecular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Molecular Partners's daily price indicators and compare them against related drivers.

When running Molecular Partners' price analysis, check to measure Molecular Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Partners is operating at the current time. Most of Molecular Partners' value examination focuses on studying past and present price action to predict the probability of Molecular Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Partners' price. Additionally, you may evaluate how the addition of Molecular Partners to your portfolios can decrease your overall portfolio volatility.